Tarivid Tablets 200Mg

Product Overview

Product Form: Tablets
Pack Size: 10's Tablets
Manufactured By: SANOFI AVENTIS
Prescription Required: Yes

Product Details

Tarivid Tablets 200mg is a potent antibiotic manufactured by SANOFI AVENTIS, designed to combat a range of bacterial infections. Each tablet contains 200mg of Ofloxacin, a fluoroquinolone that works by inhibiting bacterial DNA replication. This action effectively halts the growth of bacteria, making Tarivid a valuable option in treating various bacterial conditions.

Purposes

Tarivid Tablets are used to treat a variety of bacterial infections, including those affecting the respiratory tract, urinary tract, and skin. The active ingredient, Ofloxacin, targets bacterial DNA gyrase and topoisomerase IV, crucial enzymes in bacterial replication, thereby eliminating the infection.

Warnings

Tarivid 200mg should not be used if you have a known allergy to Ofloxacin or any other components of the medication. It is also contraindicated for individuals with a history of severe adverse reactions to quinolone antibiotics or those with epilepsy or a history of seizures. Methicillin-resistant Staphylococcus aureus (MRSA) infections are not recommended for treatment with Tarivid tabs unless susceptibility is confirmed, and caution should be exercised with empirical treatment of suspected gonococcal infections.

Adverse Effects

Common side effects of Tarivid Tabs 200mg include gastrointestinal disturbances, skin reactions, and central nervous system effects. Less frequently, patients may experience hypersensitivity reactions, peripheral neuropathy, tendinitis, or tendon rupture. For injectable forms, side effects may include pain at the injection site and thrombophlebitis. Contact your healthcare provider if any of these effects are severe or persistent.

Cautions

Before using Tarivid Tablets 200mg, consult with your doctor if you have experienced serious adverse reactions to quinolone antibiotics in the past. The use of Tarivid should be approached with caution in cases where alternative treatments are available, especially if a history of severe reactions exists. Ensure that any use in treating urinary tract infections or gonococcal infections is guided by local resistance patterns and confirmed susceptibility.